Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects
Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determi...
Saved in:
Published in | Atherosclerosis Vol. 204; no. 2; pp. 509 - 514 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ireland Ltd
01.06.2009
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0021-9150 1879-1484 1879-1484 |
DOI | 10.1016/j.atherosclerosis.2008.09.010 |
Cover
Abstract | Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1
±
1.3) were evaluated in lean (
n
=
12) and obese (
n
=
12) subgroups, and compared with age-matched lean normals (
n
=
12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA),
N
G
,
N
G
-dimethyl-
l-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired (
P
<
0.01 for both), as were their endothelium-dependent vascular responses to salbutamol (
P
<
0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all
P
<
0.05). Impairment of SNP response remained unaltered after mean 30
±
2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance. |
---|---|
AbstractList | Abstract Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1 ± 1.3) were evaluated in lean ( n = 12) and obese ( n = 12) subgroups, and compared with age-matched lean normals ( n = 12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N G , N G -dimethyl- l -arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired ( P < 0.01 for both), as were their endothelium-dependent vascular responses to salbutamol ( P < 0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P < 0.05). Impairment of SNP response remained unaltered after mean 30 ± 2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance. Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1+/-1.3) were evaluated in lean (n=12) and obese (n=12) subgroups, and compared with age-matched lean normals (n=12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N(G),N(G)-dimethyl-L-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired (P<0.01 for both), as were their endothelium-dependent vascular responses to salbutamol (P<0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P<0.05). Impairment of SNP response remained unaltered after mean 30+/-2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance.Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1+/-1.3) were evaluated in lean (n=12) and obese (n=12) subgroups, and compared with age-matched lean normals (n=12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N(G),N(G)-dimethyl-L-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired (P<0.01 for both), as were their endothelium-dependent vascular responses to salbutamol (P<0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P<0.05). Impairment of SNP response remained unaltered after mean 30+/-2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance. Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1 ± 1.3) were evaluated in lean ( n = 12) and obese ( n = 12) subgroups, and compared with age-matched lean normals ( n = 12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N G , N G -dimethyl- l-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired ( P < 0.01 for both), as were their endothelium-dependent vascular responses to salbutamol ( P < 0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P < 0.05). Impairment of SNP response remained unaltered after mean 30 ± 2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance. Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1+/-1.3) were evaluated in lean (n=12) and obese (n=12) subgroups, and compared with age-matched lean normals (n=12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N(G),N(G)-dimethyl-L-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired (P<0.01 for both), as were their endothelium-dependent vascular responses to salbutamol (P<0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P<0.05). Impairment of SNP response remained unaltered after mean 30+/-2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance. |
Author | Chan, Wai Ping A. Willoughby, Scott R. Norman, Robert J. Horowitz, John D. Liberts, Elizabeth A. Rajendran, Sharmalar Heresztyn, Tamila Saha, Mrinal Marber, Michael S. |
Author_xml | – sequence: 1 givenname: Sharmalar surname: Rajendran fullname: Rajendran, Sharmalar organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia – sequence: 2 givenname: Scott R. surname: Willoughby fullname: Willoughby, Scott R. organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia – sequence: 3 givenname: Wai Ping A. surname: Chan fullname: Chan, Wai Ping A. organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia – sequence: 4 givenname: Elizabeth A. surname: Liberts fullname: Liberts, Elizabeth A. organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia – sequence: 5 givenname: Tamila surname: Heresztyn fullname: Heresztyn, Tamila organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia – sequence: 6 givenname: Mrinal surname: Saha fullname: Saha, Mrinal organization: Cardiovascular Division, Kings College London, The Rayne Institute, St. Thomas’ Hospital, United Kingdom – sequence: 7 givenname: Michael S. surname: Marber fullname: Marber, Michael S. organization: Cardiovascular Division, Kings College London, The Rayne Institute, St. Thomas’ Hospital, United Kingdom – sequence: 8 givenname: Robert J. surname: Norman fullname: Norman, Robert J. organization: Research Centre for Reproductive Health, The Queen Elizabeth Hospital, Department of Obstetrics and Gynaecology, The University of Adelaide, Australia – sequence: 9 givenname: John D. surname: Horowitz fullname: Horowitz, John D. email: john.horowitz@adelaide.edu.au organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21630308$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19027116$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkl1rFDEUhoNU7Lb6FyQ39W7Xk_meCwVZalsoKKjXIZM5Q7NmkzUnszr_3oy7KiwI9SYDmec8HN43F-zMeYeMXQlYCRDV681KxQcMnrSdT0OrDKBZQbsCAU_YQjR1uxRFU5yxBUAmlq0o4ZxdEG0AoKhF84ydixayWohqwX589HbSE0Wjud-rMHGaXB_8Frkhroi8Nipiz7-b-MAJ9xiQ72y6shi5cj1H1_u0kTXK8n6iYXQ6Gu-4cbxLP7jvkPAXaVE5TmO3QR3pOXs6KEv44vi9ZF_eX39e3y7vP9zcrd_dL3WZF3Gp8rQx5sMghlKVSgwdVl3bDjWKTBddleeiKbFoawXFkPKBqsq7rhRVo5u-Ger8kr06eHfBfxuRotwa0mitcuhHklWdtWWaT-DLIzh2W-zlLphtykP-zioBV0dAkVZ2CMppQ3-4LCGQQ5O4NwdOp34o4PBXBXLuUG7kSYdy7lBCK1OHaX59Mq9NVHOmMShjH225OVgwhbs3GCRpg05jb0LKX_bePNr09sSkrXEmRfAVJ6SNH4NLDUohKZMgP82vbn500ABUWSuS4Prfgv9Y5CcSUPUa |
CitedBy_id | crossref_primary_10_1007_s10815_014_0190_7 crossref_primary_10_3109_09513590_2010_551566 crossref_primary_10_1155_2011_402052 crossref_primary_10_1177_1933719115570900 crossref_primary_10_1186_s12967_021_02897_0 crossref_primary_10_1016_j_pharmthera_2009_08_001 crossref_primary_10_3109_09513590_2010_507291 crossref_primary_10_1111_cen_12447 crossref_primary_10_33667_2078_5631_2019_1_1_376__53_58 crossref_primary_10_4103_0256_4947_65255 crossref_primary_10_1016_j_clnu_2014_09_015 crossref_primary_10_1002_jbm_a_37669 crossref_primary_10_1007_s10557_013_6481_x crossref_primary_10_1007_s12020_011_9461_6 crossref_primary_10_1007_s12011_018_1602_9 crossref_primary_10_1160_TH14_09_0797 crossref_primary_10_1080_0167482X_2018_1557144 crossref_primary_10_3892_etm_2011_327 crossref_primary_10_1016_j_fertnstert_2012_10_013 crossref_primary_10_1093_humupd_dmr025 crossref_primary_10_1080_01443615_2019_1603215 crossref_primary_10_17795_semj21893 crossref_primary_10_1016_j_rbmo_2011_10_010 crossref_primary_10_21070_acopen_8_2023_7830 crossref_primary_10_1097_GCO_0000000000000619 crossref_primary_10_1007_s00404_012_2358_7 crossref_primary_10_1530_EJE_11_0755 crossref_primary_10_3390_ijms23031042 crossref_primary_10_1016_j_tcm_2012_01_001 crossref_primary_10_1016_j_jacc_2012_01_066 crossref_primary_10_1016_j_mce_2010_08_002 crossref_primary_10_1111_j_1365_2265_2009_03598_x crossref_primary_10_1177_0003319709361198 crossref_primary_10_1007_s43032_022_01030_w crossref_primary_10_1186_s12902_015_0005_6 crossref_primary_10_1016_j_ejogrb_2015_05_005 crossref_primary_10_1016_j_amjmed_2014_11_007 crossref_primary_10_3389_fendo_2023_1172750 crossref_primary_10_2217_clp_09_55 crossref_primary_10_3892_ijmm_2017_3146 crossref_primary_10_1210_jc_2010_2279 crossref_primary_10_1097_SMJ_0b013e31820c0172 crossref_primary_10_1016_j_orcp_2009_08_001 crossref_primary_10_31832_smj_855493 crossref_primary_10_1371_journal_pone_0020317 crossref_primary_10_4103_ijmr_IJMR_1899_17 crossref_primary_10_1016_j_fertnstert_2010_06_058 crossref_primary_10_1093_humrep_des138 crossref_primary_10_1136_heartjnl_2014_305509 crossref_primary_10_1186_1477_7827_12_25 crossref_primary_10_1007_s10557_016_6671_4 crossref_primary_10_1155_2012_317241 crossref_primary_10_1016_j_amjmed_2012_12_015 crossref_primary_10_1016_j_gene_2017_11_049 crossref_primary_10_1016_j_phrs_2017_01_011 crossref_primary_10_1016_j_fertnstert_2010_03_049 crossref_primary_10_1210_er_2012_1003 crossref_primary_10_1016_j_niox_2011_06_005 crossref_primary_10_1007_s12020_019_02059_9 crossref_primary_10_1093_humupd_dms059 crossref_primary_10_1371_journal_pone_0247049 crossref_primary_10_1016_j_fertnstert_2010_11_036 crossref_primary_10_1592_phco_30_5_442 crossref_primary_10_1016_j_fertnstert_2010_08_030 crossref_primary_10_1016_j_ajpath_2023_08_008 crossref_primary_10_1111_cen_12137 crossref_primary_10_1016_j_tem_2019_01_005 crossref_primary_10_3109_09513590_2012_706667 crossref_primary_10_1016_j_atherosclerosis_2015_07_017 crossref_primary_10_1016_j_metabol_2018_10_008 crossref_primary_10_4137_CMWH_S9721 crossref_primary_10_1155_2015_786362 crossref_primary_10_1016_j_metabol_2015_08_010 |
Cites_doi | 10.1161/hh1301.093953 10.1016/j.ejogrb.2006.09.009 10.1093/humrep/deh098 10.1210/jc.2005-0151 10.1007/BF00280883 10.1161/hq0102.101770 10.1016/S0015-0282(16)58687-7 10.1210/jc.2003-031867 10.1210/er.2003-0004 10.1210/jc.2007-0842 10.1111/j.1365-2362.2006.01712.x 10.1210/jc.2004-1045 10.1016/j.pharmthera.2007.06.012 10.1136/jcp.2003.015271 10.1161/01.ATV.0000193622.77294.57 10.1111/j.1365-2265.2006.02645.x 10.1016/S0076-6879(84)05038-2 10.1161/01.CIR.103.10.1410 10.1210/jc.85.5.1851 10.1097/01.ogx.0000156089.26363.5b 10.1093/humrep/16.12.2606 10.1161/01.CIR.102.23.2810 10.1097/00001703-200106000-00013 10.1016/S0735-1097(01)01238-4 10.1161/01.CIR.100.2.129 10.1016/S0735-1097(02)01991-5 10.1161/01.CIR.101.16.1899 10.1111/j.1471-0528.2006.01090.x 10.1161/01.CIR.0000111245.75752.C6 10.1179/135100004225005219 10.1056/NEJMra041536 10.1016/j.jacc.2006.08.053 10.1016/j.jacc.2005.04.066 10.1007/s00395-007-0680-1 10.1210/jc.84.1.165 10.1016/j.jchromb.2004.03.020 10.1210/jc.85.7.2402 10.1210/jc.2002-021391 |
ContentType | Journal Article |
Copyright | 2008 Elsevier Ireland Ltd Elsevier Ireland Ltd 2009 INIST-CNRS |
Copyright_xml | – notice: 2008 Elsevier Ireland Ltd – notice: Elsevier Ireland Ltd – notice: 2009 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.atherosclerosis.2008.09.010 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-1484 |
EndPage | 514 |
ExternalDocumentID | 19027116 21630308 10_1016_j_atherosclerosis_2008_09_010 S0021915008006291 1_s2_0_S0021915008006291 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B M27 M41 MO0 N9A O-L O9- OAUVE OA~ OK1 OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M Z5R ZGI ZXP ~G- ~KM AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ RIG 0SF AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX ACLOT CITATION ~HD AGRNS IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c534t-a3718e3ff1f5a5a1fbe6b99f7e12c4b633185e497a04f0160663bb5168c8d8f73 |
IEDL.DBID | .~1 |
ISSN | 0021-9150 1879-1484 |
IngestDate | Sat Sep 27 19:42:29 EDT 2025 Mon Jul 21 06:05:42 EDT 2025 Mon Jul 21 09:16:59 EDT 2025 Wed Oct 01 04:59:50 EDT 2025 Thu Apr 24 23:10:41 EDT 2025 Fri Feb 23 02:28:05 EST 2024 Sun Feb 23 10:19:14 EST 2025 Tue Aug 26 17:43:42 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Polycystic ovary syndrome Endothelial function Platelets Nitric oxide Human Obesity Nutrition disorder Female sterility Cardiovascular disease Polycystic ovary Female genital diseases Thrombocytopathy Vascular disease Ovarian diseases Platelet Cyst Atherosclerosis Endothelial dysfunction Benign neoplasm Nutritional status |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c534t-a3718e3ff1f5a5a1fbe6b99f7e12c4b633185e497a04f0160663bb5168c8d8f73 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 19027116 |
PQID | 67295497 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_67295497 pubmed_primary_19027116 pascalfrancis_primary_21630308 crossref_primary_10_1016_j_atherosclerosis_2008_09_010 crossref_citationtrail_10_1016_j_atherosclerosis_2008_09_010 elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2008_09_010 elsevier_clinicalkeyesjournals_1_s2_0_S0021915008006291 elsevier_clinicalkey_doi_10_1016_j_atherosclerosis_2008_09_010 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-06-01 |
PublicationDateYYYYMMDD | 2009-06-01 |
PublicationDate_xml | – month: 06 year: 2009 text: 2009-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Ireland |
PublicationTitle | Atherosclerosis |
PublicationTitleAlternate | Atherosclerosis |
PublicationYear | 2009 |
Publisher | Elsevier Ireland Ltd Elsevier |
Publisher_xml | – name: Elsevier Ireland Ltd – name: Elsevier |
References | Vasa, Fichtlscherer, Aicher (bib20) 2001; 89 Bickerton, Clark, Meeking (bib34) 2005; 58 Legro, Kunselman, Dodson, Dunaif (bib7) 1999; 84 Bird, Draper (bib22) 1984; 105 Heresztyn, Worthley, Horowitz (bib19) 2004; 805 Kravariti, Naka, Kalantaridou (bib12) 2005; 90 Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bib27) 1985; 28 Heutling, Schulz, Nickel (bib14) 2008; 93 Dereli, Ozgen, Buyukkececi, Guney, Yilmaz (bib15) 2003; 88 Nacul, Andrade, Schwarz, Homem de Bittencourt, Spritzer (bib13) 2007; 133 (bib3) 2004; 19 Thum, Tsikas, Stein (bib37) 2005; 46 Apridonidze, Essah, Iuorno, Nestler (bib6) 2005; 90 Ehrmann (bib1) 2005; 352 Chirkov, Holmes, Willoughby (bib29) 2001; 37 Orio, Palomba, Cascella (bib10) 2004; 89 Diamanti-Kandrakis, Alexandraki, Piperi (bib31) 2006; 36 Brinkworth, Noakes, Moran, Norman, Clifton (bib35) 2006; 113 Willoughby, Stewart, Holmes, Chirkov, Horowitz (bib18) 2005; 25 Wilkinson, Hall, MacCallum (bib24) 2002; 22 Werner, Wassmann, Ahlers (bib38) 2007; 102 Legro (bib39) 2003; 24 Chirkov, Holmes, Chirkova, Horowitz (bib23) 1999; 100 Dunaif, Hoffman, Scully (bib5) 1985; 66 Sorensen, Franks, Robertson, Pennell, Collins (bib32) 2006; 65 Tarkun, Arslan, Canturk, Turemen, Sahin, Duman (bib11) 2005; 60 Paradisi, Steinberg, Hempfling (bib9) 2001; 103 Katz, Nambi, Mather (bib28) 2000; 85 Hayward, Kraidly, Webb, Collins (bib25) 2002; 40 Chirkov, Horowitz (bib16) 2007; 116 Schächinger, Britten, Zeiher (bib17) 2000; 101 Grundy (bib26) 2004; 109 Mather, Verma, Corenblum, Anderson (bib33) 2000; 85 Worthley, Holmes, Willoughby (bib30) 2007; 49 Sage, de la Lande, Stafford (bib36) 2000; 102 Norman (bib8) 2001; 13 Norman, Masters, Hague (bib4) 1996; 66 Wang, Davies, Norman (bib2) 2001; 16 Rahman, Biswas (bib21) 2004; 9 Paradisi (10.1016/j.atherosclerosis.2008.09.010_bib9) 2001; 103 Willoughby (10.1016/j.atherosclerosis.2008.09.010_bib18) 2005; 25 Grundy (10.1016/j.atherosclerosis.2008.09.010_bib26) 2004; 109 Apridonidze (10.1016/j.atherosclerosis.2008.09.010_bib6) 2005; 90 Heutling (10.1016/j.atherosclerosis.2008.09.010_bib14) 2008; 93 Wilkinson (10.1016/j.atherosclerosis.2008.09.010_bib24) 2002; 22 Katz (10.1016/j.atherosclerosis.2008.09.010_bib28) 2000; 85 Rahman (10.1016/j.atherosclerosis.2008.09.010_bib21) 2004; 9 Dereli (10.1016/j.atherosclerosis.2008.09.010_bib15) 2003; 88 Hayward (10.1016/j.atherosclerosis.2008.09.010_bib25) 2002; 40 Werner (10.1016/j.atherosclerosis.2008.09.010_bib38) 2007; 102 Chirkov (10.1016/j.atherosclerosis.2008.09.010_bib16) 2007; 116 Orio (10.1016/j.atherosclerosis.2008.09.010_bib10) 2004; 89 Wang (10.1016/j.atherosclerosis.2008.09.010_bib2) 2001; 16 Vasa (10.1016/j.atherosclerosis.2008.09.010_bib20) 2001; 89 Sorensen (10.1016/j.atherosclerosis.2008.09.010_bib32) 2006; 65 (10.1016/j.atherosclerosis.2008.09.010_bib3) 2004; 19 Norman (10.1016/j.atherosclerosis.2008.09.010_bib8) 2001; 13 Sage (10.1016/j.atherosclerosis.2008.09.010_bib36) 2000; 102 Bird (10.1016/j.atherosclerosis.2008.09.010_bib22) 1984; 105 Schächinger (10.1016/j.atherosclerosis.2008.09.010_bib17) 2000; 101 Chirkov (10.1016/j.atherosclerosis.2008.09.010_bib29) 2001; 37 Legro (10.1016/j.atherosclerosis.2008.09.010_bib7) 1999; 84 Nacul (10.1016/j.atherosclerosis.2008.09.010_bib13) 2007; 133 Mather (10.1016/j.atherosclerosis.2008.09.010_bib33) 2000; 85 Matthews (10.1016/j.atherosclerosis.2008.09.010_bib27) 1985; 28 Legro (10.1016/j.atherosclerosis.2008.09.010_bib39) 2003; 24 Kravariti (10.1016/j.atherosclerosis.2008.09.010_bib12) 2005; 90 Ehrmann (10.1016/j.atherosclerosis.2008.09.010_bib1) 2005; 352 Chirkov (10.1016/j.atherosclerosis.2008.09.010_bib23) 1999; 100 Brinkworth (10.1016/j.atherosclerosis.2008.09.010_bib35) 2006; 113 Thum (10.1016/j.atherosclerosis.2008.09.010_bib37) 2005; 46 Norman (10.1016/j.atherosclerosis.2008.09.010_bib4) 1996; 66 Bickerton (10.1016/j.atherosclerosis.2008.09.010_bib34) 2005; 58 Dunaif (10.1016/j.atherosclerosis.2008.09.010_bib5) 1985; 66 Worthley (10.1016/j.atherosclerosis.2008.09.010_bib30) 2007; 49 Diamanti-Kandrakis (10.1016/j.atherosclerosis.2008.09.010_bib31) 2006; 36 Tarkun (10.1016/j.atherosclerosis.2008.09.010_bib11) 2005; 60 Heresztyn (10.1016/j.atherosclerosis.2008.09.010_bib19) 2004; 805 |
References_xml | – volume: 60 start-page: 180 year: 2005 end-page: 181 ident: bib11 article-title: Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation publication-title: Obstet Gynecol Surv – volume: 113 start-page: 1308 year: 2006 end-page: 1314 ident: bib35 article-title: Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome publication-title: BJOG – volume: 16 start-page: 2606 year: 2001 end-page: 2609 ident: bib2 article-title: Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment publication-title: Hum Reprod – volume: 36 start-page: 691 year: 2006 end-page: 697 ident: bib31 article-title: Inflammatory and endothelial markers in women with polycystic ovary syndrome publication-title: Eur J Clin Invest – volume: 28 start-page: 412 year: 1985 end-page: 419 ident: bib27 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia – volume: 37 start-page: 1851 year: 2001 end-page: 1857 ident: bib29 article-title: Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets publication-title: J Am Coll Cardiol – volume: 100 start-page: 129 year: 1999 end-page: 134 ident: bib23 article-title: Nitrate resistance in platelets from patients with stable angina pectoris publication-title: Circulation – volume: 65 start-page: 655 year: 2006 end-page: 659 ident: bib32 article-title: Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors publication-title: Clin Endocrinol – volume: 66 start-page: 942 year: 1996 end-page: 947 ident: bib4 article-title: Hyperinsulinemia is common in family members of women with polycystic ovary syndrome publication-title: Fertil Steril – volume: 90 start-page: 5088 year: 2005 end-page: 5095 ident: bib12 article-title: Predictors of endothelial dysfunction in young women with polycystic ovary publication-title: J Clin Endocrinol Metab – volume: 46 start-page: 1693 year: 2005 end-page: 1701 ident: bib37 article-title: Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine publication-title: J Am Coll Cardiol – volume: 102 start-page: 2810 year: 2000 end-page: 2815 ident: bib36 article-title: Nitroglycerin tolerance in human vessels. Evidence for impaired nitroglycerin bioconversion publication-title: Circulation – volume: 24 start-page: 302 year: 2003 end-page: 312 ident: bib39 article-title: Polycystic ovary syndrome and cardiovascular disease: a premature association? publication-title: Endocr Rev – volume: 25 start-page: 2661 year: 2005 end-page: 2666 ident: bib18 article-title: Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes publication-title: Arterioscler Thromb Vasc Biol – volume: 49 start-page: 304 year: 2007 end-page: 310 ident: bib30 article-title: The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes. Mediation by superoxide production, resolution with intensive insulin administration publication-title: J Am Coll Cardiol – volume: 84 start-page: 165 year: 1999 end-page: 169 ident: bib7 article-title: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women publication-title: J Clin Endocrinol Metab – volume: 9 start-page: 125 year: 2004 end-page: 143 ident: bib21 article-title: Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues publication-title: Redox Rep – volume: 58 start-page: 151 year: 2005 end-page: 154 ident: bib34 article-title: Cardiovascular risk in women with polycystic ovary syndrome (PCOS) publication-title: J Clin Pathol – volume: 85 start-page: 2402 year: 2000 end-page: 2410 ident: bib28 article-title: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans publication-title: J Clin Endocrinol Metab – volume: 89 start-page: 4588 year: 2004 end-page: 4593 ident: bib10 article-title: Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome publication-title: J Clin Endocrinol Metab – volume: 805 start-page: 325 year: 2004 end-page: 329 ident: bib19 article-title: Determination of publication-title: J Chromatogr B – volume: 40 start-page: 521 year: 2002 end-page: 528 ident: bib25 article-title: Assessment of endothelial function using peripheral waveform analysis: a clinical application publication-title: J Am Coll Cardiol – volume: 13 start-page: 323 year: 2001 end-page: 327 ident: bib8 article-title: Obesity, polycystic ovary syndrome and anovulation—how are they interrelated? publication-title: Curr Opin Obstet Gynecol – volume: 93 start-page: 82 year: 2008 end-page: 90 ident: bib14 article-title: Asymmetric dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment publication-title: J Clin Endocrinol Metab – volume: 109 start-page: 433 year: 2004 end-page: 438 ident: bib26 article-title: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition publication-title: Circulation – volume: 352 start-page: 1223 year: 2005 end-page: 1236 ident: bib1 article-title: Polycystic ovary syndrome publication-title: N Engl J Med – volume: 19 start-page: 41 year: 2004 end-page: 47 ident: bib3 article-title: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) publication-title: Hum Reprod – volume: 90 start-page: 1929 year: 2005 end-page: 1935 ident: bib6 article-title: Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome publication-title: J Clin Endocrinol Metab – volume: 66 start-page: 545 year: 1985 end-page: 552 ident: bib5 article-title: Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization publication-title: Obstet Gynecol – volume: 133 start-page: 191 year: 2007 end-page: 196 ident: bib13 article-title: Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity publication-title: Eur J Obstet Gynecol Reprod Biol – volume: 105 start-page: 299 year: 1984 end-page: 305 ident: bib22 article-title: Comparative studies on different methods of malonaldehyde determination publication-title: Methods Enzymol – volume: 103 start-page: 1410 year: 2001 end-page: 1415 ident: bib9 article-title: Polycystic ovary syndrome is associated with endothelial dysfunction publication-title: Circulation – volume: 89 start-page: E1 year: 2001 end-page: E7 ident: bib20 article-title: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease publication-title: Circ Res – volume: 101 start-page: 1899 year: 2000 end-page: 1906 ident: bib17 article-title: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease publication-title: Circulation – volume: 102 start-page: 565 year: 2007 end-page: 571 ident: bib38 article-title: Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease publication-title: Basic Res Cardiol – volume: 116 start-page: 287 year: 2007 end-page: 305 ident: bib16 article-title: Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier publication-title: Pharmacol Ther – volume: 22 start-page: 147 year: 2002 end-page: 152 ident: bib24 article-title: Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function publication-title: Arterioscler Thromb Vasc Biol – volume: 88 start-page: 2263 year: 2003 end-page: 2268 ident: bib15 article-title: Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity publication-title: J Clin Endocrinol Metab – volume: 85 start-page: 1851 year: 2000 end-page: 1856 ident: bib33 article-title: Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome publication-title: J Clin Endocrinol Metab – volume: 89 start-page: E1 year: 2001 ident: 10.1016/j.atherosclerosis.2008.09.010_bib20 article-title: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease publication-title: Circ Res doi: 10.1161/hh1301.093953 – volume: 133 start-page: 191 year: 2007 ident: 10.1016/j.atherosclerosis.2008.09.010_bib13 article-title: Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity publication-title: Eur J Obstet Gynecol Reprod Biol doi: 10.1016/j.ejogrb.2006.09.009 – volume: 19 start-page: 41 year: 2004 ident: 10.1016/j.atherosclerosis.2008.09.010_bib3 article-title: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) publication-title: Hum Reprod doi: 10.1093/humrep/deh098 – volume: 90 start-page: 5088 year: 2005 ident: 10.1016/j.atherosclerosis.2008.09.010_bib12 article-title: Predictors of endothelial dysfunction in young women with polycystic ovary publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0151 – volume: 28 start-page: 412 year: 1985 ident: 10.1016/j.atherosclerosis.2008.09.010_bib27 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 22 start-page: 147 year: 2002 ident: 10.1016/j.atherosclerosis.2008.09.010_bib24 article-title: Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/hq0102.101770 – volume: 66 start-page: 942 year: 1996 ident: 10.1016/j.atherosclerosis.2008.09.010_bib4 article-title: Hyperinsulinemia is common in family members of women with polycystic ovary syndrome publication-title: Fertil Steril doi: 10.1016/S0015-0282(16)58687-7 – volume: 89 start-page: 4588 year: 2004 ident: 10.1016/j.atherosclerosis.2008.09.010_bib10 article-title: Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031867 – volume: 24 start-page: 302 year: 2003 ident: 10.1016/j.atherosclerosis.2008.09.010_bib39 article-title: Polycystic ovary syndrome and cardiovascular disease: a premature association? publication-title: Endocr Rev doi: 10.1210/er.2003-0004 – volume: 93 start-page: 82 year: 2008 ident: 10.1016/j.atherosclerosis.2008.09.010_bib14 article-title: Asymmetric dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0842 – volume: 36 start-page: 691 year: 2006 ident: 10.1016/j.atherosclerosis.2008.09.010_bib31 article-title: Inflammatory and endothelial markers in women with polycystic ovary syndrome publication-title: Eur J Clin Invest doi: 10.1111/j.1365-2362.2006.01712.x – volume: 90 start-page: 1929 year: 2005 ident: 10.1016/j.atherosclerosis.2008.09.010_bib6 article-title: Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-1045 – volume: 116 start-page: 287 year: 2007 ident: 10.1016/j.atherosclerosis.2008.09.010_bib16 article-title: Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2007.06.012 – volume: 58 start-page: 151 year: 2005 ident: 10.1016/j.atherosclerosis.2008.09.010_bib34 article-title: Cardiovascular risk in women with polycystic ovary syndrome (PCOS) publication-title: J Clin Pathol doi: 10.1136/jcp.2003.015271 – volume: 25 start-page: 2661 year: 2005 ident: 10.1016/j.atherosclerosis.2008.09.010_bib18 article-title: Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000193622.77294.57 – volume: 65 start-page: 655 year: 2006 ident: 10.1016/j.atherosclerosis.2008.09.010_bib32 article-title: Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2006.02645.x – volume: 66 start-page: 545 year: 1985 ident: 10.1016/j.atherosclerosis.2008.09.010_bib5 article-title: Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization publication-title: Obstet Gynecol – volume: 105 start-page: 299 year: 1984 ident: 10.1016/j.atherosclerosis.2008.09.010_bib22 article-title: Comparative studies on different methods of malonaldehyde determination publication-title: Methods Enzymol doi: 10.1016/S0076-6879(84)05038-2 – volume: 103 start-page: 1410 year: 2001 ident: 10.1016/j.atherosclerosis.2008.09.010_bib9 article-title: Polycystic ovary syndrome is associated with endothelial dysfunction publication-title: Circulation doi: 10.1161/01.CIR.103.10.1410 – volume: 85 start-page: 1851 year: 2000 ident: 10.1016/j.atherosclerosis.2008.09.010_bib33 article-title: Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.85.5.1851 – volume: 60 start-page: 180 year: 2005 ident: 10.1016/j.atherosclerosis.2008.09.010_bib11 article-title: Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation publication-title: Obstet Gynecol Surv doi: 10.1097/01.ogx.0000156089.26363.5b – volume: 16 start-page: 2606 year: 2001 ident: 10.1016/j.atherosclerosis.2008.09.010_bib2 article-title: Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment publication-title: Hum Reprod doi: 10.1093/humrep/16.12.2606 – volume: 102 start-page: 2810 year: 2000 ident: 10.1016/j.atherosclerosis.2008.09.010_bib36 article-title: Nitroglycerin tolerance in human vessels. Evidence for impaired nitroglycerin bioconversion publication-title: Circulation doi: 10.1161/01.CIR.102.23.2810 – volume: 13 start-page: 323 year: 2001 ident: 10.1016/j.atherosclerosis.2008.09.010_bib8 article-title: Obesity, polycystic ovary syndrome and anovulation—how are they interrelated? publication-title: Curr Opin Obstet Gynecol doi: 10.1097/00001703-200106000-00013 – volume: 37 start-page: 1851 year: 2001 ident: 10.1016/j.atherosclerosis.2008.09.010_bib29 article-title: Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(01)01238-4 – volume: 100 start-page: 129 year: 1999 ident: 10.1016/j.atherosclerosis.2008.09.010_bib23 article-title: Nitrate resistance in platelets from patients with stable angina pectoris publication-title: Circulation doi: 10.1161/01.CIR.100.2.129 – volume: 40 start-page: 521 year: 2002 ident: 10.1016/j.atherosclerosis.2008.09.010_bib25 article-title: Assessment of endothelial function using peripheral waveform analysis: a clinical application publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(02)01991-5 – volume: 101 start-page: 1899 year: 2000 ident: 10.1016/j.atherosclerosis.2008.09.010_bib17 article-title: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease publication-title: Circulation doi: 10.1161/01.CIR.101.16.1899 – volume: 113 start-page: 1308 year: 2006 ident: 10.1016/j.atherosclerosis.2008.09.010_bib35 article-title: Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome publication-title: BJOG doi: 10.1111/j.1471-0528.2006.01090.x – volume: 109 start-page: 433 year: 2004 ident: 10.1016/j.atherosclerosis.2008.09.010_bib26 article-title: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition publication-title: Circulation doi: 10.1161/01.CIR.0000111245.75752.C6 – volume: 9 start-page: 125 year: 2004 ident: 10.1016/j.atherosclerosis.2008.09.010_bib21 article-title: Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues publication-title: Redox Rep doi: 10.1179/135100004225005219 – volume: 352 start-page: 1223 year: 2005 ident: 10.1016/j.atherosclerosis.2008.09.010_bib1 article-title: Polycystic ovary syndrome publication-title: N Engl J Med doi: 10.1056/NEJMra041536 – volume: 49 start-page: 304 year: 2007 ident: 10.1016/j.atherosclerosis.2008.09.010_bib30 article-title: The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes. Mediation by superoxide production, resolution with intensive insulin administration publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.08.053 – volume: 46 start-page: 1693 year: 2005 ident: 10.1016/j.atherosclerosis.2008.09.010_bib37 article-title: Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2005.04.066 – volume: 102 start-page: 565 year: 2007 ident: 10.1016/j.atherosclerosis.2008.09.010_bib38 article-title: Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease publication-title: Basic Res Cardiol doi: 10.1007/s00395-007-0680-1 – volume: 84 start-page: 165 year: 1999 ident: 10.1016/j.atherosclerosis.2008.09.010_bib7 article-title: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.84.1.165 – volume: 805 start-page: 325 year: 2004 ident: 10.1016/j.atherosclerosis.2008.09.010_bib19 article-title: Determination of l-arginine and NG,NG- and NG,NG’-dimethyl-l-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives publication-title: J Chromatogr B doi: 10.1016/j.jchromb.2004.03.020 – volume: 85 start-page: 2402 year: 2000 ident: 10.1016/j.atherosclerosis.2008.09.010_bib28 article-title: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.85.7.2402 – volume: 88 start-page: 2263 year: 2003 ident: 10.1016/j.atherosclerosis.2008.09.010_bib15 article-title: Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2002-021391 |
SSID | ssj0004718 |
Score | 2.2594285 |
Snippet | Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk... Abstract Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 509 |
SubjectTerms | Adenosine Diphosphate Adult Albuterol - pharmacology Arginine - analogs & derivatives Arginine - blood Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Blood coagulation. Blood cells Body Composition C-Reactive Protein - metabolism Cardiology. Vascular system Cardiovascular Cohort Studies Endothelial Cells - pathology Endothelial function Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism Endothelium, Vascular - pathology Endothelium, Vascular - physiopathology Female Fundamental and applied biological sciences. Psychology Humans Inflammation Mediators - blood Malondialdehyde - blood Medical sciences Molecular and cellular biology Nitric oxide Nitric Oxide - blood Nitric Oxide Donors - pharmacology Nitroglycerin - pharmacology Nitroprusside - pharmacology Obesity - blood Obesity - complications Obesity - physiopathology Oxidative Stress Platelet Platelet Aggregation - drug effects Platelet Function Tests Platelets Polycystic ovary syndrome Polycystic Ovary Syndrome - blood Polycystic Ovary Syndrome - complications Polycystic Ovary Syndrome - physiopathology Stem Cells - pathology Time Factors Vasodilator Agents - pharmacology |
Title | Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0021915008006291 https://www.clinicalkey.es/playcontent/1-s2.0-S0021915008006291 https://dx.doi.org/10.1016/j.atherosclerosis.2008.09.010 https://www.ncbi.nlm.nih.gov/pubmed/19027116 https://www.proquest.com/docview/67295497 |
Volume | 204 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: ACRLP dateStart: 19950106 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: AIKHN dateStart: 19950106 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-1484 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0004718 issn: 0021-9150 databaseCode: AKRWK dateStart: 19700101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEA_HCYcg4rf1Y82DPvauH2myBRGPw2NV7vDBg3sLaTOBldIum11xX_zbnWnTXU5POPGlD2mSpjOTyY_MF2OvS6MMOOvixCQ2FpDingM5jRGbSlEaoRJLFt2zczm7EJ8ui8s9djLGwpBbZdD9g07vtXVoOQrUPFrM5xTji7sN8QxhHpkNEexCklvf4c-dmwcp38HNI42p9wF7s_Px6kFW53FKfM59cK0sDxMKqL3-nLqzMB6p54ayF3_Hpf35dHqP3Q3Akh8Pa7_P9qB9wA7Ogun8IfvxpWs29YbSMvPuu1lu-JisgM89N4FLYDndzHJcByyBLxpsQs5y01oOraVwrQYlltuNpxORuMrnLa_wBe8q8ND3bMC03K8ruuPxj9jF6YevJ7M4lF2I6yIXq9jkSDLInUtdYQqTugpkVZZOISNrUcmcAq5BlMokwlGCOgQtVVWkclpP7dSp_DHbb7sWnjKeFg4BkCycqh2yPTWoX60Cm-dZ4ayAiL0diazrkJOcSmM0enQ--6Z_41Gom1lq5FHE5Hb4YkjOcdOB70aO6jECFXWmxmPkphOo6yYAHzSA16n2mU70H1IasffbkVcE_V8-PrkihNt_zxBcU_6hiL0apVKjtiATkGmhW3stVW_XVRF7Mgjrjm5lkqk0lc_-f33P2e3B5kZ3VS_Y_mq5hpcI3VbVpN-bE3br-OPn2fkvKTFJuA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBZhA2mhlL7rPhId2qMbyw9pDaU0hIZNk116SCA3IVsjcDH2stoN2X_fkS3vkjaFlF58sC1Znhl9-tA8RMiHXAkFRpswUpEOU2A454CPQ-SmPM1VKiLtPLrTGZ9cpt-vsqsdcjzkwriwSo_9PaZ3aO3vHHppHs6ryuX44mxDPuM4D49dBvtumiEmj8ju0enZZLZNjxSsB2QXjYAN9sjHbZhXx7Nai73itbI-ujL_FLmc2ruXqkdzZVGApj_54u_UtFuiTp6Qx55b0qN--E_JDjTPyN7Ue8-fk5sfbb0u164yM22v1WJNh3oFtLJUeUWBpm5zluI4YAF0XuMtVC5VjabQaJexVaPRUr22blF0iqVVQwt8QNsCLHRv1qAaaleF2-axL8jlybeL40noT14IyyxJl6FKUGSQGMNMpjLFTAG8yHMjUJdlWvDE5VxDmgsVpcbVqEPeUhQZ4-NyrMdGJC_JqGkbeE0oywxyIJ4ZURrUPFMIsVqATpI4MzqFgHwehCxLX5bcnY5RyyH-7Kf8TUf-6Mxcoo4CwjfN5319jvs2_DJoVA5JqAibEleS-3Yg7uoArAcBK5m0sYzkH4YakK-blrds_V8-vn_LCDf_HiO_diWIAnIwWKVEwHBeINVAu7KSi861KwLyqjfWrdzyKBaM8Tf_P74D8mByMT2X56ezs7fkYe-Cc1tX78houVjBe2Ryy2Lfz9RfKIxMYw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polycystic+ovary+syndrome+is+associated+with+severe+platelet+and+endothelial+dysfunction+in+both+obese+and+lean+subjects&rft.jtitle=Atherosclerosis&rft.au=Rajendran%2C+Sharmalar&rft.au=Willoughby%2C+Scott+R.&rft.au=Chan%2C+Wai+Ping+A.&rft.au=Liberts%2C+Elizabeth+A.&rft.date=2009-06-01&rft.pub=Elsevier+Ireland+Ltd&rft.issn=0021-9150&rft.volume=204&rft.issue=2&rft.spage=509&rft.epage=514&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2008.09.010&rft.externalDocID=S0021915008006291 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00219150%2FS0021915009X00067%2Fcov150h.gif |